Gt Biopharma Stock Overlap Studies Exponential Moving Average
| GTBP Stock | USD 3.04 0.36 13.43% |
| Symbol |
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Exponential Moving Average is calculated by weighting recent values of GT Biopharma more heavily than older values.
GT Biopharma Technical Analysis Modules
Most technical analysis of GT Biopharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for GTBP from various momentum indicators to cycle indicators. When you analyze GTBP charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About GT Biopharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of GT Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of GT Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing GTBP Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GT Biopharma's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of GT Biopharma's intrinsic value. In addition to deriving basic predictive indicators for GT Biopharma, we also check how macroeconomic factors affect GT Biopharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 (projected) | Payables Turnover | 0.002371 | 0.002253 | Days Of Inventory On Hand | 61.05 | 86.22 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GT Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GT Biopharma's short interest history, or implied volatility extrapolated from GT Biopharma options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Investor Favorites Invested over 40 shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Automobiles and Trucks Invested over 200 shares | |
 | Driverless Cars Invested over 50 shares | |
 | Macroaxis Index Invested few shares | |
 | Impulse Invested few shares | |
 | FinTech Invested few shares | |
 | Trump Equities Invested few shares | |
 | Blockchain Invested few shares | |
Additional Tools for GTBP Stock Analysis
When running GT Biopharma's price analysis, check to measure GT Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GT Biopharma is operating at the current time. Most of GT Biopharma's value examination focuses on studying past and present price action to predict the probability of GT Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GT Biopharma's price. Additionally, you may evaluate how the addition of GT Biopharma to your portfolios can decrease your overall portfolio volatility.